Cost-benefit analysis of funding a smoking cessation program before surgery

surgery
Credit: CC0 Public Domain

For patients undergoing surgery, smoking is linked with a higher risk of experiencing complications following their procedure, and quitting smoking before surgery may help reduce this risk. A new BJS (formerly British Journal of Surgery) study examined whether a smoking cessation intervention before surgery is economically worthwhile when funded by the National Health System (NHS) in Spain.

The intervention was a combination of medical counselling and use of a 12 weeks before surgery, and the benefits were the costs avoided by averting postoperative complications if cessation was successful.

When investigators compared the net economic outcome (benefit minus cost of the intervention) and the return on investment for the intervention funded by the NHS versus the current situation without funding, they found that the benefit of funding the programme greatly outweighs the .

Smoking cessation increased by 21.7% with funding. The cost per averted smoker was €1,753 with a net benefit of €503. Given the annual cost of the intervention, the return on investment was 28.7%, equivalent to €1.29 per €1 of investment.

"There is no published study, as far as we can find, about the efficiency of health programmes or policies aimed at smoking cessation prior to planned with hospitalization. Thus, this work is unique," said senior author Javier Rejas, MD, Ph.D., of Pfizer SLU, in Spain.


Explore further

Program helps patients quit smoking before surgery

More information: C. A. Jiménez-Ruiz et al, Cost-benefit analysis of funding smoking cessation before surgery, British Journal of Surgery (2020). DOI: 10.1002/bjs.11506
Journal information: British Journal of Surgery

Provided by Wiley
Citation: Cost-benefit analysis of funding a smoking cessation program before surgery (2020, May 6) retrieved 1 June 2020 from https://medicalxpress.com/news/2020-05-cost-benefit-analysis-funding-cessation-surgery.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments